Takashi Oki Selected Research

pirmenol

9/2004

A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Oki Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 06/2013
4	Hypertrophy 09/2010 - 01/2004
4	Hypertension (High Blood Pressure) 09/2010 - 10/2004
2	Carcinoma (Carcinomatosis) 01/2021 - 06/2013
2	Infections 06/2013 - 01/2013
2	Nausea 11/2011 - 09/2004
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021
1	Proteinuria 01/2021
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021
1	Low Back Pain (Lumbago) 01/2021
1	Disease Progression 01/2021
1	Compression Fractures (Compression Fracture) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 05/2015
1	Xanthogranulomatous Pyelonephritis 06/2013
1	Inflammation (Inflammations) 06/2013
1	Bacterial Infections (Bacterial Infection) 01/2013
1	Brain Diseases (Brain Disorder) 01/2013
1	Urinary Tract Infections (Urinary Tract Infection) 01/2013
1	Epstein-Barr Virus Infections 01/2012
1	Dyspnea (Shortness of Breath) 01/2012
1	Fatigue 01/2012
1	Virus Diseases (Viral Diseases) 01/2012
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2012
1	Fibrosis (Cirrhosis) 09/2010
1	Carotid Artery Diseases 08/2010
1	Hypercholesterolemia 04/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2007
1	Cushing Syndrome 06/2007
1	Confusion (Bewilderment) 06/2007
1	Adenoma (Adenomas) 06/2007
1	Adrenal incidentaloma 06/2007
1	Systolic Heart Failure 09/2005
1	Pseudarthrosis (Pseudoarthrosis) 03/2005
1	Essential Hypertension 10/2004
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2004
1	Syncope (Fainting) 09/2004
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2004
1	Myocardial Infarction 03/2002
1	Infarction (Infarctions) 03/2002

Drug/Important Bio-Agent (IBA)

3	Telmisartan (Micardis)FDA Link 09/2010 - 09/2009
2	Dobutamine FDA LinkGeneric 11/2007 - 03/2002
1	AntigensIBA 01/2021
1	pazopanib FDA Link 01/2021
1	NivolumabIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	ThrombospondinsIBA 01/2021
1	Phospholipase A2 ReceptorsIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 05/2015
1	Sorafenib (BAY 43-9006)FDA Link 05/2015
1	MTOR InhibitorsIBA 05/2015
1	Everolimus FDA Link 05/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2013
1	ProcalcitoninIBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2013
1	Coloring Agents (Dyes)IBA 01/2012
1	AnticoagulantsIBA 11/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2008
1	oxidized low density lipoproteinIBA 04/2008
1	CholesterolIBA 04/2008
1	pitavastatin (itavastatin)FDA Link 04/2008
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2005
1	Angiotensin Receptor AntagonistsIBA 09/2005
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2005
1	Losartan (Cozaar)FDA LinkGeneric 10/2004
1	Midodrine (Midon)FDA LinkGeneric 09/2004
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 09/2004
1	pirmenolIBA 09/2004
1	pentadecanoic acidIBA 01/2004

Therapy/Procedure

6	Therapeutics 01/2021 - 09/2004
1	Combined Modality Therapy 01/2021
1	Nephrectomy 01/2021
1	Neoadjuvant Therapy 01/2021
1	Chemoprevention 05/2015
1	Castration 05/2015
1	Transplantation 01/2012
1	Kidney Transplantation 01/2012
1	Aftercare (After-Treatment) 10/2004